Thermo Fisher Scientific has obtained 510(k) clearance from the FDA for its Applied BioSystems TaqPath COVID-19 Diagnostic PCR Kit. Previously authorized for emergency use, this clearance allows clinical and public health laboratories to adopt an in vitro diagnostic (IVD) workflow. The kit detects RNA from SARS-CoV-2 using nasopharyngeal and anterior nasal swabs and employs a…